Menu Menu
[gtranslate]

UK treads genetic grey area with three-person IVF milestone

The deliveries of eight infants in the UK via a three-person IVF technique have astonished the world. Nonetheless, its connection to a largely prohibited type of genome editing has raised concerns among the scientific community.

Science has once again expanded its frontiers in a landmark procedure that conceived babies via IVF through the DNA of three people. If you feel that this contradicts the fundamentals of conception that we were all taught in school, youโ€™re not alone. Nevertheless, the process saw the birth of eight healthy babies in the UK, with one set of identical twins.

The mothers in this trial were all in high-risk of passing on a mitochondrial mutation to their babies. In the long term, these mutations would have causes life-threatening diseases to the children as they grew older, ranging from developmental delay to neurological problems. Hence, doctors in the UK devised a method to introduce healthy mitochondrial DNA from a donor into the egg, thereby, eliminating repercussions of the mitochondrial dysfunction.

Though this procedure opens doors to ensure the birth of healthy babies, it also raises new ethical concerns โ€“ particularly when it comes to germline engineering.

What is germline engineering?

The world has seen constant advancements in gene editing therapies. However, all these therapies are somatic in nature. This means that current techniques target non-reproductive cells without altering the underlying genetic makeup of the individual, which is where the germline comes into play.

Germline cells contain the full set of an individualโ€™s genetic information (DNA) through gametes. When gametes combine during conception, they create a new genetic makeup derived from both parents with cells that can reproduce.

That said, editing beyond the germline may introduce unintended genetic changes known as off-target effects. These can be inherited by all future generations, including the risks of new genetic diseases, which in the moment of editing can be extremely difficult to foresee.

Moreover, there is the problem of consent with individuals who are not yet born. They cannot consent to the changes in genetic makeup, raising concerns about the autonomy of countless generations.

Incidentally, this sort of tinkering with genes is also closely linked to the idea of designer babies, whose genetic makeup has been deliberately altered to reflect a specific trait. For all these reasons and much more, the idea of germline engineering has largely been classified to be unethical.

The worldwide ban

Altering the core of human biology is so controversial that it has prompted a widespread international ban on germline genome editing. Just a few months ago, major organisations involved in regenerative medicine came together, calling for a 10-year global suspension of germline editing. This extends a moratorium first suggested after the 2018 incident involving Chinese scientist He Jiankui, whose embryo editing led to live births and global condemnation.

In fact, over 70 countries have explicitly prohibited such editing to initiate pregnancy. In the United States, federal law forbids the clinical application of germline editing and public funding for such research. While the European Union and much of the world follow similar restrictions on the procedure, research is treated with more flexibility.

Some countries permit germline editing for research under strict regulatory conditions. These are usually limited to early embryonic stages, which are up to 14 days, complying with international regulations. These studies aim to understand the safety and biological mechanisms of genome editing, and evaluate risks of potential procedures.

The UKโ€™s perspective

Before examining the UKโ€™s regulatory framework, itโ€™s important to understand why the recent IVF birth involving mitochondrial DNA (mtDNA) qualifies as germline engineering. Mitochondrial donation, as given by the donor, introduces heritable mtDNA into an embryo, passing it down through the maternal line. While it affects inheritable DNA, it does not alter identity-related traits.

Although the UK maintains a strict regulatory framework for germline editing, mitochondrial donation is treated differently. The government and regulators distinguish it from nuclear gene editing because it replaces faulty mitochondria, responsible for cellular energy production, without modifying nuclear DNA, which contains most genetic traits.

Following rigorous research and ethical debate, the UK parliament passed the Human Fertilisation and Embryology (Mitochondrial Donations) Regulations in 2015. While procedures such as the one that resulted in the eight births are legal, they are subject to strict regulation by the Human Fertilisation and Embryology Authority (HFEA). The HFEA only grants licences after thorough assessments of a clinicโ€™s expertise and systems to safely perform the procedure.

Thankfully, all eight infants are showing positive results at the moment. Nevertheless, the newfound procedureโ€™s future effects are not yet fully known, making long-term follow-ups and research essential to their livelihoods.

Accessibility